New Science Ventures
SlowingNew York, NYBiotechnology, PharmaceuticalsLast fund filed May 2014
1 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| New Science Ventures Fund III (Offshore) | May 2014 | $100M | $12M | 6 |
| New Science Ventures Fund III | May 2014 | $100M | $25M | 28 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
2 partners are named across this firm’s filings, 1 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Somu Subramaniam | Slowing | Aerospace & defense, Biotech & pharma, Medical devices | 13 | 1 |
| Thomas LavinNot on the current fund | Quiet | Digital health, Aerospace & defense, Biotech & pharma | 5 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of New Science Ventures’s own portfolio companies, based on 16 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of New Science Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| NSV 2018 New Horizons | 16 | ABL Space Systems, ACUITY LINK, Alexar Therapeutics, BIOSCALE, BRIGHTVOLT, Directed Sensing, Ferric, Glydways, JUVENTAS THERAPEUTICS, Light Sciences Oncology, PAKAL TECHNOLOGIES, PerceptiMed, PHASE FOUR, SILICON SPACE TECHNOLOGY, SVELTE MEDICAL SYSTEMS, VASCULAR THERAPIES |
| Nexeption Capital | 2 | Alexar Therapeutics, Light Sciences Oncology |
| Khosla Ventures | 1 | Glydways |
| Pivotal bioVenture Partners | 1 | Light Sciences Oncology |
A shared board seat: a company where filings name a New Science Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.